Evidence map›Paper›PMID 25260352›Full record

ArticleHeart rhythm2015

Novel Timothy syndrome mutation leading to increase in CACNA1C window current.

Nicole J Boczek, Erin M Miller, Dan Ye, Vladislav V Nesterenko, David J Tester, Charles Antzelevitch, Richard J Czosek, Michael J Ackerman, Stephanie M Ware

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Heart rhythm, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Guideline
  2. Geno- and phenotypic characteristics and clinical outcomes ofFrontiers in cardiovascular medicine · 2022
    Pooled it
  3. Pooled it
  4. Inactivation of CaV1 and CaV2 channels.The Journal of general physiology · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. CACNA1C-Related Channelopathies.Handbook of experimental pharmacology · 2023
    Review
  11. Disruption of mitochondrial and lysosomal functions by humanFrontiers in molecular neuroscience · 2023
    Article
  12. Towards Zebrafish Models of CNS Channelopathies.International journal of molecular sciences · 2022
    Review
  13. Increased CaScientific reports · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Nicole J BoczekCenter for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota; Mayo Graduate School, Mayo Clinic, Rochester, Minnesota.
Erin M MillerThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Dan YeDepartment Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota.
Vladislav V NesterenkoDepartment of Pharmacology, Masonic Medical Research Laboratory, Utica, New York.
David J TesterDepartment Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota.
Charles AntzelevitchDepartment of Pharmacology, Masonic Medical Research Laboratory, Utica, New York.
Richard J CzosekThe Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Michael J AckermanDepartment Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota; Department of Medicine (Division of Cardiovascular Diseases), Mayo Clinic, Rochester, Minnesota; Department of Pediatrics (Division of Pediatric Cardiology), Mayo Clinic, Rochester, Minnesota. Electronic address: ackerman.michael@mayo.edu.
Stephanie M WareDepartments of Pediatrics and Medical and Molecular Genetics, Indiana University School of Medicine, Herman B Wells Center for Pediatric Research, Indianapolis, Indiana. Electronic address: stware@iu.edu.
Mayo Clinic · USCincinnati Children's Hospital Medical Center · USMasonic Medical Research Laboratory · USIndiana University – Purdue University Indianapolis · USWinnMed · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)R01HD042569 · NICHD · MAYO CLINIC ROCHESTER · PI ACKERMAN, MICHAEL JOHN · 2002 to 2017
$6.9M
NCATS NIH HHS UL1 TR000135NCATS NIH HHS UL1TR000135NICHD NIH HHS R01 HD042569
6 · The paper itself

Abstract

backgroundTimothy syndrome (TS) is a rare multisystem genetic disorder characterized by a myriad of abnormalities, including QT prolongation, syndactyly, and neurologic symptoms. The predominant genetic causes are recurrent de novo missense mutations in exon 8/8A of the CACNA1C-encoded L-type calcium channel; however, some cases remain genetically elusive.

objectiveThe purpose of this study was to identify the genetic cause of TS in a patient who did not harbor a CACNA1C mutation in exon 8/A, and was negative for all other plausible genetic substrates.

methodsDiagnostic exome sequencing was used to identify the genetic substrate responsible for our case of TS. The identified mutation was characterized using whole-cell patch-clamp technique, and the results of these analyses were modeled using a modified Luo-Rudy dynamic model to determine the effects on the cardiac action potential.

resultsWhole exome sequencing revealed a novel CACNA1C mutation, p.Ile1166Thr, in a young male with diagnosed TS. Functional electrophysiologic analysis identified a novel mechanism of TS-mediated disease, with an overall loss of current density and a gain-of-function shift in activation, leading to an increased window current. Modeling studies of this variant predicted prolongation of the action potential as well as the development of spontaneous early afterdepolarizations.

conclusionThrough expanded whole exome sequencing, we identified a novel genetic substrate for TS, p.Ile1166Thr-CACNA1C. Electrophysiologic experiments combined with modeling studies have identified a novel TS mechanism through increased window current. Therefore, expanded genetic testing in cases of TS to the entire CACNA1C coding region, if initial targeted testing is negative, may be warranted.

Indexed as

Autistic DisorderCalcium Channels, L-TypeHeart BlockHumansInfantLong QT SyndromeMaleMutationSyndactylyCACNA1C protein, humanCalcium Channels, L-TypeCACNA1CGeneticsTimothy syndromeWhole exome sequencingWindow current

Identifiers

PMID25260352
PMCPMC4907369
OpenAlexW2107242483

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.